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Abstract: 
 
The evolution of the selected ion flow tube, SIFT, used to study ion-molecule 
reactions of interstellar significance, to the selected ion flow tube mass spectrometry, 
SIFT-MS, analytical technique is described briefly. Focus is placed on the application 
of SIFT-MS to breath analysis and its potential for the detection of volatile 
biomarkers of disease including respiratory pathogens. Typical concentrations of 
particular volatile breath biomarkers are given and their associations with specific 
diseases are indicated. A special case is the identification and quantification of 
gaseous hydrogen cyanide that is elevated in the exhaled breath of patients with cystic 
fibrosis and is now taken as a biomarker of Pseudomonas aeruginosa infection of the 
airways. 
 
Introduction: 
 
This short paper is intended as homage to a good friend and colleague, Professor 
Warren Lenney, a senior paediatric respiratory physician of great repute, on the 
occasion of his retirement. The title of this paper is perhaps curious but, hopefully, it 
will be understood by the way it is structured and developed and how the content is 
relevant to respiratory medicine and to Professor Lenney’s legacy. 
 
The ultimate focus of this story is the real time detection and quantification of volatile 
trace compounds in exhaled breath and how they can be exploited as non-invasive 
biomarkers of normal physiology and patho-physiology and of respiratory pathogens 
and metabolic disease. Realization of these desirable objectives has been greatly 
facilitated by the development at Keele University of a new analytical technique that 
we call selected ion flow tube mass spectrometry, SIFT-MS. The origin of this novel 
analytical method in the 1970s resides in the need to explain how the complex 
molecules observed in interstellar clouds, which includes many biogenic-type 
molecules, can be synthesised under the extreme conditions of very low temperatures 
and pressures that pertain to interstellar clouds  [1]. It was hypothesized that the 
chemistry largely involved the reactions of positively charged ions with neutral atoms 
and molecules. To study this ion chemistry new instrumentation was required that 
could provide the desired kinetics data on ion-molecule reactions to facilitate the 
quantitative modelling of this chemistry. Thus, the selected ion flow tube technique, 
SIFT, was born in the laboratory of the author (in collaboration with Nigel G. Adams) 
at Birmingham University, UK. 
 
 
 
Figure 1 Composition of air and exhaled breath. The concentrations of major 
breath compounds and the nominal concentrations of some volatile metabolites are 
shown in parts per billion by volume, ppbv, on a logarithmic scale. See the listed 
references for further details. 
 
 
 
SIFT and SIFT-MS: 
 
In the SIFT the ions whose reactions are to be studied are generated in an external ion 
source and injected via a quadrupole mass filter into fast flowing helium carrier gas. 
Thus, a wide variety of ions, selected according to their mass-to-charge ratio, m/z, can 
be injected into flowing helium and their reactions studied with a wide range of 
molecular species at thermal energies, to include many reactions that are judged to be 
important in naturally occurring media such as the terrestrial ionosphere, other 
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planetary atmospheres and interstellar gas clouds [2]. The large amount of data 
acquired using SIFT instruments, especially the rate coefficients, k, for hundreds of 
ion-molecule reactions, has contributed greatly to the understanding of interstellar 
chemistry and resulted in the adoption of this technique in many laboratories 
worldwide.  
 
Being cognizant of the discovery of trace biogenic molecules in exhaled breath in the 
1990s, the author (with Patrik Spanel) realised that the SIFT technique could be 
inverted to form the SIFT-MS analytical method by which the concentrations of trace 
molecules could be determined in real time in ambient air and exhaled breath if the k 
values were known for specific and relevant reactions of biogenic molecules. Thus, 
SIFT-MS has been demonstrated to be a valuable and versatile analytical method that 
uniquely compliments those available to analytical science. The timeline for this 
development and the challenges that had to be met are described in depth in a recent 
paper [3]. Ambient air or exhaled breath can be directly sampled at a known rate into 
the SIFT-MS instrument, obviating sample collection into bags or onto traps, and 
analysed in real time with the results immediately available to the scientist or clinician 
for rapid interpretation. Breath is exhaled at the sample entry port of the SIFT-MS; on 
inhalation, the ambient air is sampled and analysed, as is important in breath analysis 
research. Details of the SIFT-MS method, the physics and ion chemistry involved, a 
line diagram showing the structure of the instrumentation and its application to breath 
analysis, have been given in recent authoritative reviews [4, 5].  
 
Breath analysis: 
 
The remainder of this short paper focuses on breath analysis aimed at supporting 
clinical diagnosis and therapeutic monitoring. Professor Lenney and his clinical 
colleagues have made and continue to make important contributions to this new 
subject area, principally by exploiting SIFT-MS. It is often stated that hundreds of 
trace biogenic molecules are present in exhaled breath even of healthy individuals. 
However, relatively few have been quantified accurately enough to be useful as 
reliable biomarkers of physiological status; even fewer have had reference ranges 
established for healthy individuals. The important point to be made is that the data 
acquisition rate using SIFT-MS can be very large. Since breath sampling is carried out 
directly, non-invasively and painlessly without time-consuming sample collection and 
preparation, accurate breath analysis can be carried out for significant cohorts of 
healthy volunteers and patients in short times. In a recent study, the exhaled breath of 
some 70 healthy individuals was analysed for two different compounds 
simultaneously in a single morning. Some of the trace compounds detected and 
quantified in breath by SIFT-MS are indicated in Figure 1. The association of 
particular trace metabolites with disease states are also indicated together with the 
concentration reference ranges for ostensibly healthy individuals resulting from 
longitudinal inter-individual and intra-individual studies [4, 5]. Careful scrutiny of  
Figure 1 reveals that the trace biomarkers are present in concentrations ranging from 
sub-ppbv (parts-per-billion by volume) to a few ppmv (parts-per-million by volume), 
i.e. many orders-of-magnitude in concentration below that of carbon dioxide and 
water vapour. Much more could be said about the data in Figure 1; rather, references 
to the results of individual studies of the specific molecules indicated and their 
biogenic significance are given in the listed review papers. However, it is worth 
noting the results of just two SIFT-MS studies that reveal the potential of SIFT-MS 
for breath analysis in medicine. The close association of exhaled breath pentane with 
inflammatory bowel disease, IBD, both Crohn’s disease and ulcerative colitis [6], and 
the association of breath acetic acid with gastro-intestinal reflux disease, GERD [7] 
are impressive examples. These studies involved significant cohorts of patients and 
healthy controls and identified just single biomarker organic compounds for these 
disease conditions.  
 
HCN and PA: 
 
Finally, focus is given to those areas of breath research to which Professor Lenney 
and his younger colleagues (notably Drs. Will Carroll, Beth Enderby and, most 
recently, Fran Gilchrist) have made a very important contribution. This is the 
discovery that volatile hydrogen cyanide, HCN, (which happens to be one the 
interstellar molecules studied by SIFT) is released by the Pseudomonas aeruginosa, 
PA, bacterium that colonises the respiratory tract of those suffering from cystic 
fibrosis, CF. This was first discovered during the SIFT-MS analysis of the headspace 
of plate cultures of PA [8]. This initiated a study over a decade guided by Professor 
Lenney that has ultimately established that gaseous HCN is elevated in the nose-
exhaled breath of CF patients. Thus, a non-invasive biomarker of airways colonisation 
by PA has been identified that can be used to track the eradication of this bacterium to 
the benefit of the CF patients. The timeline for these thorough and extensive studies, 
which involved parallel in vitro and in vivo measurements, is reported in a recent 
paper [9]. These studies, so imaginatively conceived by Professor Lenney, are being 
continued and expanded at Keele by his successor clinicians supported by SIFT-MS 
scientists. The most recent work involves in vitro studies of the trace compounds 
emitted by other common respiratory bacteria, such as S. aureus, S. pneumoniae and 
H. influenza, in the search for and the identification of volatile non-invasive 
biomarkers of these pathogens [10]. 
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